Navigation Links
Price Plays Part in Perceived Power of Medication
Date:3/4/2008

it to be worse, it can actually be worse," Ariely said.

An important implication of this study is how does one present discounted drugs to patients without them thinking they are inferior, Ariely said. "How do we give discounted drugs to people we want to give discounted drugs without giving them the negative side effects?" he asked.

The problem is having people understand the price of the drug is not a function of the effectiveness of the drug. Ariely wonders if discounted drugs and small co-pays give people the impression that the drugs are of lower quality.

One way of reducing the effect of cost on the perception of efficacy is when patients understand why they are getting the discounts they are getting, Ariely said. Another strategy is for doctors to explain to their patients the benefits of the drug and that cost is not related to the performance of the drug.

One expert agreed that price is tied to perceived value, whether it involves cars or drugs. Overcoming the perception about drugs and price is something that doctors can help patients do.

"These findings fit exactly with the way we Americans are," said Daniel E. Moerman, the William E. Stirton Professor of Anthropology at the University of Michigan, in Dearborn. "We all think expensive cars are better, but even a cheap car will get you to the store."

Moerman thinks that since price plays such a pivotal role in people's perception of drug efficacy, many people probably doubt the quality and efficacy of generic drugs.

Although generic drugs are pharmacologically the same as brand-name drugs, "meaningfully, I can't help it, they are not the same," Moerman said. "This means that physicians are going to have to compensate in some other way."

Doctors need to take the time to educate their patients about the benefit of the medication they are prescribing, Moerman said.

"If you have patients whose drugs are shifting t
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cataract Surgery: A Bargain, Despite the Price
2. Albemarle to Increase Price of Ibuprofen
3. PCMA Statement on New Average Manufacturer Price (AMP) Legislation
4. Pricey Running Shoes Not Worth It: Study
5. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
6. Canadians welcome HPV vaccine -- but not at any price
7. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
8. Solae Announces Global Price Increase for Soy Protein Ingredients
9. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Price Plays Part in Perceived Power of Medication
(Date:3/31/2015)... 31, 2015 Beckman Coulter is sponsoring ... Analysis,” with Borries Demeler, which will highlight approaches used ... webinar is free to attend and will be broadcast ... recent years, sophisticated new methods for sedimentation data ... AUC technology in a wide range of technology sectors, ...
(Date:3/31/2015)... Horizon Blue Cross Blue Shield of New ... combat health insurance fraud resulted in $45.4 million in ... and losses avoided -- in 2014. The $45.4 million ... its fraud fighting, Special Investigations Unit (SIU) in 1983. ... members $261 million. , “Our SIU has progressively ...
(Date:3/31/2015)... March 31, 2015 St. Joseph Medical ... network of leading healthcare systems, major physician groups and ... for the benefit of patients. The health information exchange ... supports well coordinated care throughout the continuum of services ... long tradition of providing services to a broad cross ...
(Date:3/31/2015)... 2015 The Denver Regional Council of ... planning an array of public activities which include invitations ... and a Unity Parade and Rally at Denver Union ... – a national day of advocacy on April 9 ... funding. , The effort is being led by the ...
(Date:3/31/2015)... 31, 2015 Juvent Sports ( http://www.juventsports.com ... PGA Merchandise show in Orlando. At the show, former ... Maggie Will was interviewed and she shared the life-changing ... since she began integrating the Juvent Pro Micro-Impact Platform™ ... been so instrumental to her chronic back pain recovery ...
Breaking Medicine News(10 mins):Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 2Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 3Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 3Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 3
... 7 Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... and marketer of customized nutritional supplements, today announced ... Randell Weaver,s employment with NAI ended.NAI also announced ... with Wells Fargo Bank. Among other changes ...
... Legislation Aimed at Protecting Medicare Beneficiaries Introduced on ... 7 Physical therapy ... limited by arbitrary financial caps under legislation introduced ... according to the American Physical Therapy Association (APTA). ...
... Acute lymphoblastic leukemia is most common pediatric cancer , , ... leukemia cells predicts which children with acute lymphoblastic leukemia ... online Jan. 7 in the New England Journal ... physicians fine-tune treatment for different subsets of patients. , ...
... SB 203, known as Emily,s Law, has received ... in the state of Ohio. Named after Emily Jerry, ... pharmacy technicians. The law, which was originally sponsored by ... National Pharmacy Technician Association. Emily,s Story , Emily ...
... used to treat heart failure, slowed cell growth, study ... a drug used for many years to treat irregular ... cancer-fighting agent, researchers report. , Cancer cells need to ... these cells are oxygen-deprived and need to switch on ...
... A medical revolution emerges when,technology blends with smart ... new Smart OR(TM) - a specialized neurosurgical suite ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081016/CLTH057 ... configuration of advanced imagery and mapping technology, the ...
Cached Medicine News:Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:Heart Drug May Be a Cancer Fighter 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3
(Date:3/31/2015)... AUBURN HILLS, Mich. , March 31, 2015 /PRNewswire-USNewswire/ ... xenon (PU-UX) was highlighted in a recently published study ... an influential infection prevention research team, including Curtis ... robot which was run for the same length of ... a pulsed xenon (PU-UV) unit.  The results showed surprisingly ...
(Date:3/31/2015)... Accelerated orthodontic treatment will be a ... 2015 Annual Session, May 15-19, as seven of ... AcceleDent ® . Manufactured by OrthoAccel ® ... is a FDA-cleared, Class II medical device that ... 50 percent with just 20 minutes of daily ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... report "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, ... Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - ... global Life Science and Chemical Instrumentation Market is ... CAGR of 6.9% from 2014 to 2019. ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5
... -- ImClone,Systems Incorporated and Bristol-Myers Squibb Company ... ERBITUX(R) (Cetuximab) plus,gemcitabine (a chemotherapy) in patients ... did not meet its,primary endpoint of improving ... Oncology Group (SWOG), a cancer,center network sponsored ...
... ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ --,Telik, ... its,multicenter Phase 2 trial of the triplet ... paclitaxel will be,presented at the 98th annual ... (AACR) in Los Angeles. Preclinical studies of,cellular ...
Cached Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: